Sporikova, Z., Koudelakova, V., Trojanec, R. & Hajduch, M. Genetic Markers in Triple-Detrimental Breast Most cancers. Clin Breast Most cancers 18, e841–e850 (2018).
Received, Okay.-A. & Spruck, C. Triple-negative breast most cancers remedy: Present and future views (Overview). Int J Oncol 57, 1245–1261 (2020).
Meng, X., Cai, Y., Chang, X. & Guo, Y. A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast most cancers. Entrance Endocrinol (Lausanne) 14, 1119105 (2023).
Gluz, O. et al. Triple-negative breast most cancers–present standing and future instructions. Ann Oncol 20, 1913–1927 (2009).
Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast most cancers: challenges and alternatives of a heterogeneous illness. Nat Rev Clin Oncol 13, 674–690 (2016).
Maqbool, M., Bekele, F. & Fekadu, G. Therapy Methods Towards Triple-Detrimental Breast Most cancers: An Up to date Overview. Breast Most cancers (Dove Med Press) 14, 15–24 (2022).
Kreike, B. et al. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Most cancers Res 9, R65 (2007).
Kelstrup, C. D. et al. Efficiency Analysis of the Q Exactive HF-X for Shotgun Proteomics. J Proteome Res 17, 727–738 (2018).
Gillet, L. C. et al. Focused information extraction of the MS/MS spectra generated by data-independent acquisition: a brand new idea for constant and correct proteome evaluation. Mol Cell Proteomics 11, O111.016717 (2012).
Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome construction and performance. Nature 537, 347–355 (2016).
Faktor, J., Sucha, R., Paralova, V., Liu, Y. & Bouchal, P. Comparability of focused proteomics approaches for detecting and quantifying proteins derived from human most cancers tissues. Proteomics 17, (2017).
Barkovits, Okay. et al. Reproducibility, Specificity and Accuracy of Relative Quantification Utilizing Spectral Library-based Information-independent Acquisition. Mol Cell Proteomics 19, 181–197 (2020).
Shao, W. & Lam, H. Tandem mass spectral libraries of peptides and their roles in proteomics analysis. Mass Spectrom Rev 36, 634–648 (2017).
Tsou, C.-C. et al. DIA-Umpire: complete computational framework for data-independent acquisition proteomics. Nat Strategies 12, 258–264 (2015). 7 p following 264.
Yang, Y. et al. In silico spectral libraries by deep studying facilitate data-independent acquisition proteomics. Nat Commun 11, 146 (2020).
Muntel, J. et al. Advancing Urinary Protein Biomarker Discovery by Information-Unbiased Acquisition on a Quadrupole-Orbitrap Mass Spectrometer. J Proteome Res 14, 4752–4762 (2015).
Lapcik, P. et al. A big-scale assay library for focused protein quantification in renal cell carcinoma tissues. Proteomics e2100228 https://doi.org/10.1002/pmic.202100228 (2021).
García-Adrián, S. et al. Molecular characterization of triple destructive breast most cancers formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomics. Proteomics 22, e2100110 (2022).
Meng, X., Liu, D. & Guan, Y. Advances within the software of label-free quantitative proteomics strategies in malignancy analysis. Biomed Chromatogr 37, e5667 (2023).
Meier, F. et al. On-line Parallel Accumulation-Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer. Mol Cell Proteomics 17, 2534–2545 (2018).
Meier, F. et al. diaPASEF: parallel accumulation-serial fragmentation mixed with data-independent acquisition. Nat Strategies 17, 1229–1236 (2020).
Zhang, F., Ge, W., Ruan, G., Cai, X. & Guo, T. Information-Unbiased Acquisition Mass Spectrometry-Based mostly Proteomics and Software program Instruments: A Glimpse in 2020. Proteomics 20, e1900276 (2020).
Bruderer, R. et al. Extending the bounds of quantitative proteome profiling with data-independent acquisition and software to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteomics 14, 1400–1410 (2015).
Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, Okay. S. & Ralser, M. DIA-NN: neural networks and interference correction allow deep proteome protection in excessive throughput. Nat Strategies 17, 41–44 (2020).
Skowronek, P. & Meier, F. Excessive-Throughput Mass Spectrometry-Based mostly Proteomics with dia-PASEF. Strategies Mol Biol 2456, 15–27 (2022).
Demichev, V. et al. dia-PASEF information evaluation utilizing FragPipe and DIA-NN for deep proteomics of low pattern quantities. Nat Commun 13, 3944 (2022).
Muntel, J. et al. Surpassing 10 000 recognized and quantified proteins in a single run by optimizing present LC-MS instrumentation and information evaluation technique. Mol Omics 15, 348–360 (2019).
Bouchal, P. et al. Breast Most cancers Classification Based mostly on Proteotypes Obtained by SWATH Mass Spectrometry. Cell Rep 28, 832–843.e7 (2019).
Bouchal, P. et al. Biomarker discovery in low-grade breast most cancers utilizing isobaric steady isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) primarily based quantitative proteomic evaluation. J Proteome Res 8, 362–373 (2009).
Stejskal, Okay., Potěšil, D. & Zdráhal, Z. Suppression of peptide pattern losses in autosampler vials. J Proteome Res 12, 3057–3062 (2013).
Říhová, Okay. et al. Caspase-9 Is a Constructive Regulator of Osteoblastic Cell Migration Recognized by diaPASEF Proteomics. J Proteome Res https://doi.org/10.1021/acs.jproteome.3c00641 (2024).
Lou, R. et al. Benchmarking generally used software program suites and evaluation workflows for DIA proteomics and phosphoproteomics. Nat Commun 14, 94 (2023).
Monash Proteomics and Metabolomics Platform & Monash Bioinformatics Platform, Monash College. DIA-Analyst: An interactive web-platform to investigate and visualize proteomics information preprocessed with Spectronaut and DIA-NN. https://analyst-suites.org/apps/dia-analyst/.
Wang, S., Zheng, W., Hu, L., Gong, M. & Yang, H. MixProTool: A Highly effective and Complete Net Device for Analyzing and Visualizing Multigroup Proteomics Information. J Comput Biol 25, 1123–1127 (2018).
Perez-Riverol, Y. et al. The PRIDE database assets in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 50, D543–D552 (2022).
Lapcik, P. et al. A hybrid DDA/DIA-PASEF-based assay library for a deep proteotype characterization of triple-negative breast most cancers. PRIDE Archive https://identifiers.org/satisfaction.venture:PXD047793 (2023).
